Recommendations for bone mineral density reporting in Canada

Canadian Association of Radiologists Journal

Volumn 56, Issue 3, 2005, Pages 178-188

  Siminoski, Kerry ^a   Leslie, William D ^b   Frame, Heather ^b   Hodsman, Anthony ^c   Josse, Robert G ^d   Khan, Aliya ^e   Lentle, Brian C ^f   Lévesque, Jacques ^g   Lyons, David J ^h   Tarulli, Giuseppe ⁱ   Brown, Jacques P ^j  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g LAVAL UNIVERSITY   (Canada)

^h Renfrew Victoria Hospital   (Canada)

ⁱ Hurnber Regional Hospital   (Canada)

^j UNIVERSITÉ LAVAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

AGE; BONE DENSITY; CANADA; CONSENSUS; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; HUMAN; MEDICAL DOCUMENTATION; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE;

AGED; BONE DENSITY; CANADA; DENSITOMETRY, X-RAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK ASSESSMENT;

EID: 23644457647     PISSN: 08465371     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Khan AA, Brown J, Faulkner K, Kendler D, Lentle B, Leslie W, et al. Standards and guidelines for performing central dual x-ray densitometry from the Canadian Panel of International Society for Clinical Densitometry. J Clin Densitom 2002;5:247-57.
2. Khan AA, Bachrach L, Brown JP, Hanley DA, Josse RG, Kendler DL, et al. Standards and guidelines for performing central dual-energy x-ray densitometry in premenopausal women, men, and children. J Clin Densitom 2004;7:51-64.
3. Gluer CC, Blake G, Lu Y, Blunt BA, Jergas M, Genant HK. Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int 1995;5:262-70.
4. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. WHO Technical Report Series. Geneva: WHO; 1994.
5. Brown JP, Josse RG. Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167:S1-S36.
6. Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001;12:989-95.
7. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
8. Genest J, Frohlich J, Fodor G, McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ 2003;169:921-4.
9. Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004;35:375-82.
10. Adachi JD, Olszynski WP, Hanley DA, Hodsman AB, Kendler DL, Siminoski KG, et al. Management of corticosteroid-induced osteoporosis. Semin Arthritis Rheum 2000;29:228-51.